1. Home
  2. ATYR vs INR Comparison

ATYR vs INR Comparison

Compare ATYR & INR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • INR
  • Stock Information
  • Founded
  • ATYR 2005
  • INR 2017
  • Country
  • ATYR United States
  • INR United States
  • Employees
  • ATYR N/A
  • INR N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • INR
  • Sector
  • ATYR Health Care
  • INR
  • Exchange
  • ATYR Nasdaq
  • INR NYSE
  • Market Cap
  • ATYR 327.0M
  • INR 267.4M
  • IPO Year
  • ATYR 2015
  • INR 2025
  • Fundamental
  • Price
  • ATYR $2.79
  • INR $17.33
  • Analyst Decision
  • ATYR Strong Buy
  • INR Strong Buy
  • Analyst Count
  • ATYR 6
  • INR 6
  • Target Price
  • ATYR $18.60
  • INR $28.17
  • AVG Volume (30 Days)
  • ATYR 1.6M
  • INR 468.9K
  • Earning Date
  • ATYR 03-13-2025
  • INR 01-01-0001
  • Dividend Yield
  • ATYR N/A
  • INR N/A
  • EPS Growth
  • ATYR N/A
  • INR N/A
  • EPS
  • ATYR N/A
  • INR N/A
  • Revenue
  • ATYR $235,000.00
  • INR $259,022,000.00
  • Revenue This Year
  • ATYR $1,387.23
  • INR N/A
  • Revenue Next Year
  • ATYR $873.22
  • INR N/A
  • P/E Ratio
  • ATYR N/A
  • INR $21.37
  • Revenue Growth
  • ATYR N/A
  • INR 60.16
  • 52 Week Low
  • ATYR $1.42
  • INR $14.83
  • 52 Week High
  • ATYR $4.66
  • INR $23.00
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 33.98
  • INR N/A
  • Support Level
  • ATYR $3.20
  • INR N/A
  • Resistance Level
  • ATYR $3.94
  • INR N/A
  • Average True Range (ATR)
  • ATYR 0.22
  • INR 0.00
  • MACD
  • ATYR -0.09
  • INR 0.00
  • Stochastic Oscillator
  • ATYR 4.97
  • INR 0.00

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About INR INFINITY NATURAL RESOURCES INC

Infinity Natural Resources Inc is an oil and natural gas exploration and production company. The group focused on developing unconventional reserves in Appalachia. It is engaged in acquiring, exploring, and developing properties for producing oil, natural gas, and natural gas liquids (NGLs) from underground reservoirs.

Share on Social Networks: